Key Takeaways
- The American Society of Human Genetics (ASHG) has launched an Artificial Intelligence (AI) Initiative to promote responsible and effective AI use across human genetics and genomics.
- The initiative will address technical and ethical considerations, create governance standards, and provide ongoing education for researchers, clinicians, and patients.
- Core components include an invitation‑only AI Summit, a two‑day virtual symposium, and a published report with a “roadmap for the future.”
- A multidisciplinary Task Force chaired by Marylyn Ritchie, PhD, will guide the effort, with representation from academia, industry, and government.
- Sponsorship from Ambry Genetics and Amazon Web Services (AWS) underscores broad support for the initiative’s goals.
Overview of the ASHG AI Initiative Launch
Today, the American Society of Human Genetics (ASHG) announced the launch of the ASHG Artificial Intelligence (AI) Initiative, a multi‑part effort designed to promote and advance the responsible, effective use of AI across human genetics and genomics. The news release, distributed via Newswise, emphasized that AI is “rapidly transforming the ways scientists and clinicians interpret genomic data, improve diagnosis, advance personalized treatment strategies, and discover new therapeutic insights.” By creating a coordinated framework, ASHG hopes to ensure that the genetics community can harness AI’s power while mitigating risks related to bias, privacy, and reproducibility.
Goals and Motivations Behind the Initiative
ASHG President Susan A. Slaugenhaupt, PhD, articulated the initiative’s vision, stating, “We are entering a new era in human genetics and genomics—accelerating discovery, sharpening interpretation, and expanding what’s possible in research and care.” She added that the Initiative “brings leaders together to tackle important questions about responsible use of AI in research and develop actionable recommendations that strengthen both scientific rigor and public confidence.” The overarching goal is to help the global genetics and genomics community use AI responsibly so that large data sets can be analyzed and scientific breakthroughs fostered.
Core Components of the Initiative
The ASHG AI Initiative comprises three primary deliverables. First, an invitation‑only, in‑person AI Summit will convene thought leaders from academia, government, and industry to discuss challenges and opportunities in governing and standardizing AI’s use in human genetics and genomics. Second, a two‑day virtual symposium will showcase cutting‑edge research into AI applications within the field. Third, a published report will synthesize recommendations and outcomes from both events, coupled with an actionable “roadmap for the future” that ASHG will use to advance AI application and governance in research.
Structure and Leadership of the AI Initiative Task Force
Guiding the initiative is the ASHG AI Initiative Task Force, composed of leaders in research, clinical genetics, and industry. The task force will shape the initiative’s direction, design convening agendas, and oversee the development of core deliverables. Marylyn Ritchie, PhD, Chief AI Officer at the Medical University of South Carolina, chairs the group. Other members include Donavan Cheng, PhD (Ambry Genetics); Eric Green, MD, PhD (Illumina); Stephanie Kraft, JD (Geisinger); Danielle Luz, MD (Stanford University School of Medicine); Ankit Malhotra, PhD (AWS); Natalie Pageler, MD (Stanford University School of Medicine); Robert Nussbaum, MD (University of California, San Francisco); Olga Troyanskya, PhD (Princeton University); Jennifer Wagner, JD, PhD (Pennsylvania State University); Nephi Walton, MD (University of Utah); and Kenny Wong, MS, CGC (xCures).
Statements from ASHG Leadership and Task Force Chair
In announcing the initiative, Slaugenhaupt highlighted the collaborative nature of the effort: “This Initiative brings leaders together to tackle important questions about responsible use of AI in research and develop actionable recommendations that strengthen both scientific rigor and public confidence.” Marylyn Ritchie echoed this sentiment, noting that the task force’s diverse expertise will be critical in “addressing the technical and ethical considerations of using AI in human genetics and genomics” while creating a framework that benefits researchers, clinicians, and patients alike.
Sponsorship and Collaborative Support
The initiative receives valuable support from Ambry Genetics and Amazon Web Services (AWS), both of which are listed as sponsors and participants. Their involvement reflects a shared commitment to advancing AI responsibly within the genomics ecosystem. ASHG expressed gratitude for their partnership, indicating that industry engagement will help ensure that the initiative’s recommendations are practical, scalable, and aligned with real‑world needs.
About the American Society of Human Genetics
ASHG describes itself as the leading global organization advancing the science of human genetics and genomics. Representing nearly 8,000 researchers, clinicians, genetic counselors, educators, and other professionals, the Society drives progress in understanding the human genome and its role in health and disease. ASHG fosters innovation and collaboration through its flagship events and publications—including the ASHG Annual Meeting and its peer‑reviewed journals The American Journal of Human Genetics and Human Genetics and Genomics Advances. The Society also champions science advocacy, supports the next generation of genetics professionals, and promotes responsible policies and public engagement in genetics.
Implications for the Genetics and Genomics Community
By launching the AI Initiative, ASHG aims to fill a critical gap: a unified, ethically grounded approach to AI that can be adopted across labs, clinics, and industry settings. The forthcoming summit, symposium, and roadmap are expected to produce concrete guidelines on data governance, algorithm transparency, and validation standards—issues that have long hindered widespread AI adoption in genetics. As AI continues to evolve, the initiative’s emphasisongoing education and stakeholder dialogue will help ensure that the technology serves to enhance, rather than undermine, the rigor and trustworthiness of genomic research and patient care.
https://www.newswise.com/articles/ashg-launches-initiative-to-advance-responsible-effective-use-of-artificial-intelligence-in-human-genetics-and-genomics